Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors.
- DOI
- 10.1155/2022/2253436
- Published
- 2022
- Container
- Journal of immunology research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1155/2022/2253436,
title = {Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors.},
author = {Zhang M and Wang L and Liu W and Wang T and De Sanctis F and Zhu L and Zhang G and Cheng J and Cao Q and Zhou J and Tagliabue A and Bronte V and Yan D and Wan X and Yu G},
year = {2022},
journal = {Journal of immunology research},
doi = {10.1155/2022/2253436},
url = {https://doi.org/10.1155/2022/2253436}
}RIS
TY - JOUR TI - Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors. AU - Zhang M AU - Wang L AU - Liu W AU - Wang T AU - De Sanctis F AU - Zhu L AU - Zhang G AU - Cheng J AU - Cao Q AU - Zhou J AU - Tagliabue A AU - Bronte V AU - Yan D AU - Wan X AU - Yu G PY - 2022 JO - Journal of immunology research DO - 10.1155/2022/2253436 UR - https://doi.org/10.1155/2022/2253436 ER -
APA
M, Z., L, W., W, L., T, W., F, D. S., L, Z., G, Z., J, C., Q, C., J, Z., A, T., V, B., D, Y., X, W., & G, Y. (2022). Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors.. Journal of immunology research. https://doi.org/10.1155/2022/2253436
Source records
- pubmed · retrieved 2026-09-26T00:48:41.077Z